Washout periods and carryover effects
In a crossover trial, participants receive both treatments sequentially, but the timing of that sequence matters greatly. The study design includes a washout period between the two phases - a rest interval where the participant receives neither treatment, allowing the first drug or intervention to clear from the body.
Carryover effects occur when the first treatment influences outcomes in the second phase. Strong washout periods mitigate this, but some conditions (like behavioral interventions or chronic disease states) make true washout impossible, which is why crossover designs aren't suitable for all research questions.
Within-subject comparison and statistical power
Because each participant serves as their own control, crossover trials require fewer total participants than parallel-group studies with similar statistical power. Comparing someone's response to treatment A against their response to treatment B eliminates between-person variation, one of the largest sources of noise in biomedical studies.
This efficiency advantage assumes the condition is stable and measurement is consistent across periods. Rapidly progressive diseases or unstable conditions reduce the validity of within-subject comparisons.